Last Updated: 23 April 2026

Aviva plc (LSE: AV) is a FTSE 100 multi-line UK insurance and wealth manager that completed its £3.7bn acquisition of Direct Line Insurance Group on 1 July 2025, making it now the largest UK personal-lines insurer alongside its UK Life, Wealth, Health, Canada GI and Aviva Investors operations. FY2025 results (released 5 March 2026) hit the company’s 2026 operating-profit target one year early: group operating profit £2,203m (+25%), IFRS profit after tax £1,054m (+50%), General Insurance GWP £14.1bn (+18%) including DLG’s H2 contribution, Solvency II shareholder cover ratio 180%, total dividend 39.3p (+10%) and a £350m share buyback announced. Direct Line cost-synergy guidance has been twice upgraded to £225m run-rate by 2028 with an additional >£500m of capital synergies expected to lift Solvency II by >10pp once regulatory approval lands ~end-2026. New 2028 medium-term targets are 11% operating-EPS CAGR, IFRS RoE >20% and cumulative cash remittances >£7bn. With the Q1 trading update on 14 May 2026 and AGM on 6 May 2026 just ahead, this report pulls together segment mix, financials, the DLG deal, valuation and the latest 48-hour activity entirely from Aviva’s own RNS, results announcements and shareholder updates — no analyst opinions, no price targets. For live charts and watchlists see our live charts, the economic calendar, and the community forum.

1. Company Snapshot

Name	Aviva plc
Ticker	LSE: AV (FTSE 100); ADR AVVIY; ISIN GB00BPQY8M80
Sector	Insurance — multi-line (General Insurance, Life/Retirement, Wealth, Health, Aviva Investors)
Headquarters	80 Fenchurch Street, London EC3M 4AE; operational hub Wellington Row, York
Heritage	Hand in Hand Fire & Life (1696); Norwich Union (1797); modern Aviva formed Feb 2000 via CGU plc + Norwich Union (CGNU); rebranded Aviva July 2002. Direct Line Insurance Group absorbed 1 July 2025.
CEO	Dame Amanda Blanc DBE (Group CEO since July 2020)
CFO	Charlotte Jones (since 5 September 2022)
Chair	George Culmer
Employees	~36,000 globally at year-end 2025 (up from ~29,091 in 2024 reflecting DLG addition)
Customers	~21m UK customers (~4 in 10 UK adults); ~25m globally
FY2025 group operating profit	£2,203m (+25% YoY)
FY2025 IFRS profit after tax	£1,054m (+50%)
FY2025 GI GWP	£14,145m (+18%)
Solvency II ratio	180% (FY2025)
Total dividend (FY2025)	39.3p (+10%)
Market cap (22 Apr 2026)	~£19.25bn at 638.20p
Website	aviva.com

2. Bull Case vs Bear Case

Bull Case

• Direct Line acquisition completed 1 July 2025 makes Aviva the largest UK personal-lines insurer (~21% combined motor share post-deal); already £174m H2 2025 operating-profit contribution from DLG.
• Synergy guidance twice upgraded: cost synergies £125m → £225m run-rate by 2028 (~£40m run-rate by year-end 2025); >£500m of capital synergies identified, expected to lift Solvency II by >10pp upon regulatory approval ~end-2026.
• Hit 2026 operating-profit target a year early: £2.2bn FY25 operating profit (vs >£2bn target); IFRS RoE 17.5% (vs 15.7%); IWR Wealth +36% to £175m operating profit; Aviva Investors AUM £234bn (+18%) with record net flows ~£11bn.
• Capital-light shift: 56% of FY24 operating profit from capital-light businesses; DLG addition tilts further to GI/Wealth/Health.
• £350m buyback running March–August 2026; final dividend 26.2p paid 14 May 2026; total 2025 dividend 39.3p (+10%); progressive dividend policy.
• BPA franchise — £4.6bn in FY25 (12% share of £38.2bn UK PRT market); Aviva Investors originated £3.5bn of real-asset spread for the annuity book.

Bear Case

• Direct Line integration is the largest deal in years; multi-year IT migration carries cost-overrun and disruption risk; ~£350m total cost-to-achieve (cost synergies) plus ~£50m (capital synergies). Insurance Times reports ~400 DLG staff have already exited.
• Solvency II ratio reduced to 180% (FY24: 203%) reflecting DLG funding — less buffer than the historic 200%+ level (though by design, within target range).
• Weather/CAT exposure: Canada COR improved to 95.6% (from 98.5%) but Ireland Storm Éowyn pushed Irish COR up 3.3pp to 98.1%; Canadian severe-weather frequency rising structurally.
• Motor pricing/claims cycle: UK motor profitability sensitive to claims inflation, EV repair complexity (specialist parts, battery write-offs), Whiplash reform / OIC tariff legal-cost dynamics.
• BPA competition intensifying with private capital entrants (Brookfield/Just, Apollo/PIC, Blackstone/L&G partnership) potentially pressuring future margins.
• Equity-market sensitivity in Wealth/Aviva Investors fees on £234bn AUM.

3. What Does Aviva Actually Do?

Aviva is a UK-headquartered multi-line insurance and wealth manager. Following the 2020–2022 disposal programme (France, Italy, Poland, Singapore, Vietnam, Indonesia, Turkey, Hong Kong) returning ~£7.5bn of proceeds, and the 2025 acquisition of Direct Line, the business is now concentrated in three core markets: UK & Ireland (the dominant geography), Canada and a small Ireland presence.

• UK & Ireland General Insurance. Motor, home, commercial/SME, specialty (Probitas Lloyd’s syndicate). Now includes Direct Line, Churchill, Privilege, Green Flag and NIG brands alongside Aviva. FY2025 GWP £9.79bn (+27%), undiscounted COR 94.1%.
• UK & Ireland Insurance, Wealth & Retirement (IWR).
  • Retirement — Bulk Purchase Annuities (BPA / DB pension de-risking), Individual Annuities, Equity Release (#1 by loan book). FY25 operating profit £711m (−5%; volume-led BPA discipline kept margin tight).
  • Protection & Health — life protection (post AIG UK Protection acquisition 2023), private medical insurance. Health in-force premiums £1.1bn (+12%); 2026 target £100m operating profit.
  • Wealth — Aviva Workplace pensions, Aviva Platform (IFA & D2C), Aviva Investors. FY25 Wealth operating profit £175m (+36%); AUM £234bn (+18%); net flows ~£11bn.
• Canada General Insurance. Personal lines (auto, property), commercial lines — #2 player nationally. FY25 GWP £4.36bn (+2%); undiscounted COR 95.6% (FY24: 98.5%).
• Aviva Investors. Group asset management arm (~£234bn AUM); originates real-asset spread (£3.5bn in 2025) for the annuity book; external net flows £0.7–0.9bn.

4. The Business Model

Aviva makes money through three income streams:

1. Underwriting profit (General Insurance) — premiums minus claims and expenses. Group COR target sub-94%; FY2025 undiscounted COR 94.1% UK&I and 95.6% Canada (group discounted COR 90.4%).
2. Investment spread / new-business margin (Life & Retirement) — earning a margin on assets backing annuity liabilities. Aviva Investors originates real-asset spread for the BPA book (£3.5bn in 2025).
3. Recurring fees on AUM (Wealth, Aviva Investors) — fee on £234bn AUM platform/workplace; capital-light, scaling.

Under CEO Blanc, the explicit "capital-light shift" strategy has rebalanced toward fee-based Wealth, Health and General Insurance and away from capital-intensive Life. 56% of FY2024 operating profit came from capital-light businesses; the DLG addition pushes the GI weighting further still.

Capital framework: Solvency II is the binding capital regime. FY2025 Solvency II shareholder cover ratio 180% (FY24: 203%); debt leverage ratio 30.1% (FY24: 28.9%) reflecting DLG-acquired £260m Tier 2 + £350m RT1 plus Aviva’s £500m March RT1 issuance. £7.1bn surplus capital at year-end. UK BPA market reached £38.2bn in 2025 with Aviva at £4.6bn / 12% share — volumes lower than 2024’s £7.8bn but Aviva remained disciplined on pricing.

Subsidy/regulatory-credit dependency: minimal. Aviva does not rely on government incentives or tax credits in the way EV or renewable-energy companies do. Policy exposure is concentrated in Solvency II reform (UK Solvency II / Matching Adjustment changes), FCA conduct supervision (motor commission disclosure, premium finance review), and the FCA’s industry-wide motor finance redress scheme — the latter affects motor lenders directly, not Aviva (which is a marketplace customer of finance, not a primary lender on auto loans).

5. Financial Health

Five-year revenue, profit and capital trend (£ millions, source: Aviva annual results announcements)

Metric	FY21 (IFRS4)	FY22 (IFRS17 restated)	FY23	FY24	FY25
Group operating profit	2,300	~1,350	1,467	1,767	2,203
IFRS profit after tax	2,036	(1,139)	1,106	705	1,054
GI gross written premiums	8,756	9,749	10,888	12,204	14,145
Total dividend / share (p)	22.05	31.0	33.4	35.7	39.3
Solvency II ratio	244%	212%	207%	203%	180%
Shares outstanding (year-end, basic)	~3.85bn	~2.78bn	~2.74bn	~2.71bn	~3.02bn (post-DLG)
Wealth AUM (£bn)	158	147	170	198	234

Note: Aviva adopted IFRS 17 / IFRS 9 from 1 January 2023, so 2021 figures are on a different accounting basis; 2022 was restated. The 2020–2023 disposal programme returned ~£4.75bn to shareholders (B share scheme £3.75bn + £1bn buyback completed March 2022). AIG UK Protection was acquired in April 2023 and Probitas (Lloyd’s) in 2024.

Aviva does not publish a fully comparable quarterly P&L; the Q1 and Q3 announcements are trading updates rather than full income statements, so the conditional quarterly revenue + gross-margin chart is not appropriate for this stock.

6. Valuation & Market Data

Metric	Value	Notes / source date
Share price	638.20p	Close 22 April 2026 (intra-week 638–644p)
Market cap	~£19.25bn	22 April 2026
Enterprise value	~£13.89bn
Trailing P/E (TTM, IFRS)	~24.1x	IFRS basic EPS ~27p
Forward P/E (operating EPS basis)	~10.6–13.0x	Operating EPS 56.0p in FY25
P/B	~1.74x	Book value per share 351p
Dividend (FY25 total)	39.3p	Final 26.2p paid 14 May 2026
Dividend yield (trailing)	~6.1–6.2%
52-week range	525.40p – ~700.60p	High around Q1 2026 results day
Beta (5-year)	0.63
Solvency II cover ratio	180%	FY25; surplus £7.1bn
Shares outstanding	~3.02 billion	Post-DLG share issuance
Buyback authority	£350m	March–August 2026 execution window

7. What Are They Building / What’s Coming?

• Direct Line integration. Cost-synergy guidance twice upgraded: original £125m → current £225m run-rate by 2028; ~£40m already at run-rate by year-end 2025. Total cost-to-achieve ~£350m. Capital synergies of >£500m identified, expected to improve Solvency II by >10pp upon regulatory approval expected end-2026 (implementation cost ~£50m). DLG already contributed £174m operating profit in H2 2025.
• New 2028 medium-term targets (set at FY25 results): operating EPS CAGR 11% (2025–28); IFRS RoE >20%; cumulative cash remittances >£7bn (2026–28).
• BPA pipeline. UK PRT market expected to remain c.£40–50bn p.a.; new entrants (Brookfield/Just, Apollo/PIC, Blackstone/L&G partnership) intensifying competition; Aviva pursuing disciplined pricing.
• Health. Targeting £100m operating profit by 2026; in-force premiums £1.1bn (+12% in 2025).
• Wealth. Targeting £280m operating profit by 2027 (FY25 £175m); 544 new workplace scheme wins in 2025.
• AI deployment in claims, underwriting and customer service flagged at FY25 results.
• Capital returns: £350m buyback running March–August 2026; final dividend 26.2p ex 26 March 2026, payment 14 May 2026.

8. Competitive Landscape

Aviva competes across multiple distinct insurance markets. The most relevant for the stock today is UK personal lines (where it is now the largest player post-DLG) and UK BPA / Pension Risk Transfer (where it is mid-pack but disciplined).

UK personal lines / motor (post-DLG):

Competitor	Approx UK motor share	Notes
Aviva (incl. Direct Line)	~21% combined	10.5% Aviva + 10.8% DLG (pre-deal); now largest UK personal-lines insurer
Admiral Group (LSE: ADM)	~14%	Includes Admiral, Bell, Diamond, elephant, Veygo, Gladiator
Hastings Group	~7–9%	Owned by Sampo + Rand Merchant
Allianz UK (incl. LV= GI broker)	~6–7%	Rebranding LV= broker as Allianz
AXA UK	~5–6%
esure Group	~3–4%

UK BPA (Pension Risk Transfer) 2025 (£38.2bn total, LCP data): Legal & General £10.2bn / 27%; Pension Insurance Corporation £6.8bn / 18%; Rothesay £5.2bn / 14%; Aviva £4.6bn / 12%; Standard Life/Phoenix, M&G, Just Group and Royal London making up the balance.

Other: Wealth/workplace competes with Scottish Widows (Lloyds), Standard Life (Phoenix), Royal London, L&G Workplace, AJ Bell, Hargreaves Lansdown, abrdn, M&G. Canada GI: Intact Financial (#1), Definity, Desjardins, TD Insurance, Wawanesa.

9. Leadership and Ownership

Executive team: Dame Amanda Blanc DBE (Group CEO since July 2020; previously Zurich EMEA CEO, AXA UK CEO, Towergate; began career as Commercial Union graduate trainee; non-executive director at BP); Charlotte Jones (Group CFO since 5 September 2022; previously CFO of RSA Insurance Group, Jupiter Fund Management; senior finance roles at Credit Suisse and Deutsche Bank); George Culmer (Chair; previously Chair of Rothesay; ex-CFO Lloyds Banking Group, ex-CFO RSA).

Other executive directors named on April 2026 PDMR RNS: Douglas Brown (CEO Insurance, Wealth & Retirement); Jason Storah (CEO UK & Ireland General Insurance); James Hillman (Group Chief Risk Officer); Mark Versey (CEO Aviva Investors); Navinder Dhillon (CEO Aviva Canada); Pippa Lambert (Non-Executive Director).

Holder	Stake	Notes
BlackRock, Inc.	9.14% (276.1m shares)	Largest disclosed institutional holder
The Vanguard Group	5.44% (164.5m)
Capital Research & Management	5.19% (156.7m)
Hargreaves Lansdown Asset Mgmt	4.11% (124.0m)
Dodge & Cox	3.87% (116.9m)
Aberdeen Group plc	3.61% (109.1m)
Aviva ESOP (employee plan)	2.83%

Recent insider activity (last 6 months): the most material disclosure is the 16 April 2026 PDMR RNS — multiple PDMRs purchased shares under Aviva’s All Employee Share Ownership Plan and Global Matching Share Plan on 15 April at 639p / 634p (Douglas Brown 40 shares, James Hillman 40, Mark Versey 40, Jason Storah 32, Navinder Dhillon 62 via Global Matching Share Plan, Pippa Lambert 227 via NED Share Purchase Scheme); Jason Storah also sold 285 shares at 625p on 13 April 2026. Activist Cevian Capital (held ~5% in 2021) appears to have exited.

10. Risks and Challenges

• Direct Line integration execution. Aviva’s largest deal in years; multi-year IT migration of legacy DLG systems carries cost-overrun and disruption risk. £350m total cost-to-achieve (cost synergies) plus ~£50m (capital synergies). Insurance Times reports ~400 DLG staff have already exited during integration.
• Motor insurance pricing/claims cycle. UK motor profitability sensitive to claims inflation, EV repair complexity (specialist parts, battery write-offs), legal costs (Whiplash reform / OIC tariff). Pricing wars in motor remain a structural feature.
• Weather catastrophe exposure — particularly Canada (rising frequency of severe weather; FY25 saw elevated CAT activity) and Ireland (Storm Éowyn pushed Irish COR up 3.3pp to 98.1% in 2025).
• BPA longevity and reinsurance assumptions. Annuity book sensitive to longevity tables and reinsurance pricing/availability; growing private-capital competition (Brookfield, Apollo, Blackstone partnerships) may pressure margins.
• Regulatory. FCA scrutiny of motor commission disclosure; UK Solvency II reform implementation (matching adjustment changes); FCA premium finance review; SDR (Sustainability Disclosure Requirements) for Aviva Investors.
• Interest rate sensitivity. Falling long rates compress annuity new-business margins and capital generation; rising rates pressure equity-market-linked Wealth fees.
• Equity-market sensitivity. Wealth/Aviva Investors fee income tied to AUM levels (£234bn); a 10% market drawdown materially impacts fee revenue.
• Solvency II ratio reduction to 180% leaves less buffer than the 200%+ historic level, although this is by design post-DLG and within management’s target range.
• Competition in personal lines — Admiral, Allianz/LV=, esure, Hastings.

11. Recent Developments

• 21–23 April 2026. No company-initiated RNS in the past 48 hours other than routine "Transaction in Own Shares" notices under the £350m buyback programme (daily, 07:00 BST). Blackout period ahead of the 14 May Q1 trading update is limiting other announcements.
• 17 April 2026 — Buyback continuation RNS at 07:00.
• 16 April 2026 — Director/PDMR Shareholding RNS. Multiple PDMRs purchased shares under All Employee SOP and Global Matching Share Plan on 15 April at 639p / 634p. Jason Storah also sold 285 shares at 625p on 13 April 2026 (separately disclosed).
• 13–15 April 2026. Daily "Transaction in Own Shares" RNS at 07:00 covering the £350m buyback execution.
• 5 March 2026 — FY2025 Results. Operating profit £2,203m (+25%); IFRS profit after tax £1,054m (+50%); total dividend 39.3p (+10%); Solvency II 180%; £350m buyback announced; new 2028 targets (11% EPS CAGR, RoE >20%, cumulative cash >£7bn). 2026 operating-profit target hit one year early.
• March 2026 — Notice of AGM 2026: 9am Wednesday 6 May 2026, Wellington Row, York YO90 1WR.
• December 2025 — shareholder update; ongoing DLG integration milestones.
• 13 November 2025 — Q3 2025 Trading Update. Operating profit on track to exceed £2bn (2026 target hit a year early); GI premiums +12% to £10bn at 9M; COR 94.4% undiscounted / 90.4% discounted; Wealth net flows £8.3bn; BPA YTD £3.9bn. Direct Line cost synergies upgraded from £125m to £225m and capital synergies >£500m flagged.
• August 2025 — Interim Results. H1 operating profit £1,068m (+22%); interim dividend 13.1p; UK&I GI operating profit +50% to £430m; AIG Life UK Protection integration complete.
• 1 July 2025 — Direct Line acquisition completed. Following CMA Phase 1 unconditional clearance and FCA/PRA approvals; Court Order delivered to Registrar same day. Deal value ~£3.7bn ($4.65bn): 0.2867 new Aviva shares + 129.7p cash + up to 5p dividend per DLG share = 275p; 73% premium to undisturbed price of 27 Nov 2024. Aviva legacy holders ~87.5% of combined entity, former DLG holders ~12.5%.

12. Key Dates Coming Up

• 6 May 2026 — 2026 AGM, Wellington Row, York YO90 1WR (09:00).
• 14 May 2026 — Q1 2026 Trading Update.
• 14 May 2026 — FY2025 final dividend payment (26.2p) — ex-div was 26 March 2026.
• March–August 2026 — £350m share buyback execution window (RNS daily).
• August 2026 — H1 2026 Interim Results — interim dividend declared (estimated).
• November 2026 — Q3 2026 Trading Update / In Focus event (estimated).
• End-2026 — Direct Line capital synergies regulatory approval expected (>£500m / >10pp Solvency II uplift).
• March 2027 — FY2026 Results (estimated).

Related

For live charts and watchlists, see our live charts. UK macro data and BoE rate decisions move insurance valuations — they’re on the economic calendar. Discuss this report in the community forum, and browse more company research on the blog.

Disclaimer: Research only. This article is for information and discussion purposes. It is not investment advice, not a recommendation to buy or sell any security, and does not take your personal circumstances into account. All financial figures come from Aviva plc results announcements, RNS and shareholder updates; market data is as of the dates stated. Always do your own research and consult a qualified adviser before making investment decisions.